BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16183526)

  • 21. Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours.
    Plöckinger U; Wiedenmann B
    Neuroendocrinology; 2004; 80 Suppl 1():35-8. PubMed ID: 15477715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology of somatostatin in breast cancer.
    Watt HL; Kharmate G; Kumar U
    Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates.
    Li M; Becnel LS; Li W; Fisher WE; Chen C; Yao Q
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):381-7. PubMed ID: 16314822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin-receptor mediated diagnosis and treatment in gastrointestinal neuroendocrine tumours (GEP-NET's).
    Oberg K
    Rocz Akad Med Bialymst; 2005; 50():62-8. PubMed ID: 16358941
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatostatin, cortistatin and their receptors in tumours.
    Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
    Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal growth factors and neoplasia.
    Evers BM
    Am J Surg; 2005 Aug; 190(2):279-84. PubMed ID: 16023446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
    Grozinsky-Glasberg S; Grossman AB; Korbonits M
    Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular biology, pharmacology and signal transduction of 5 cloned human somatostatin receptors].
    Fehmann HC; Arnold R
    Z Gastroenterol; 1996 Nov; 34(11):767-74. PubMed ID: 9045539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
    Kos-Kudła B;
    Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
    [No Abstract]   [Full Text] [Related]  

  • 31. The puzzle of somatostatin: action, receptors, analogues and therapy.
    Panteris V; Karamanolis DG
    Hepatogastroenterology; 2005; 52(66):1771-81. PubMed ID: 16334776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function and expression of somatostatin receptors of the endocrine pancreas.
    Strowski MZ; Blake AD
    Mol Cell Endocrinol; 2008 May; 286(1-2):169-79. PubMed ID: 18375050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues.
    Van Eijck CH
    Br J Surg; 2005 Nov; 92(11):1333-4. PubMed ID: 16237740
    [No Abstract]   [Full Text] [Related]  

  • 34. The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina?
    Thermos K; Bagnoli P; Epelbaum J; Hoyer D
    Pharmacol Ther; 2006 Jun; 110(3):455-64. PubMed ID: 16274747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of the expression of somatostatin receptors in digestive endocrine tumours.
    Capurso G; Panzuto F; Delle Fave G
    Dig Liver Dis; 2010 Mar; 42(3):173-4. PubMed ID: 20117969
    [No Abstract]   [Full Text] [Related]  

  • 36. Signal transduction of somatostatin receptors negatively controlling cell proliferation.
    Ferjoux G; Bousquet C; Cordelier P; Benali N; Lopez F; Rochaix P; Buscail L; Susini C
    J Physiol Paris; 2000; 94(3-4):205-10. PubMed ID: 11087998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic abnormalities of somatostatin receptors in pituitary tumors.
    Lania A; Mantovani G; Spada A
    Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
    Rindi G; Candusso ME; Solcia E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical endocrinology and metabolism. The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders.
    Low MJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):607-22. PubMed ID: 15533778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation and function of somatostatin receptors.
    Olias G; Viollet C; Kusserow H; Epelbaum J; Meyerhof W
    J Neurochem; 2004 Jun; 89(5):1057-91. PubMed ID: 15147500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.